Pancreatic Cancer Research

ResearcherVita-Salute San Raffaele UniversityActive in the last 2 years

Matteo Tacelli

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2642-6694; OpenAlex author ID A5018012577, A5104318087. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 3 papers · 2024: none · 2025: 4 papers · 2026: 1 paper

Papers 10

  1. Glucagon-like Peptide-1 receptor agonists are not associated with increased risk of pancreatic cancer: A systematic review and meta-analysis. Last author DOI 10.1016/j.pan.2026.04.005↗
  2. Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional… Co-author DOI 10.1002/ijc.35196↗
  3. Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancer. Co-author DOI 10.1016/j.dld.2024.05.017↗
  4. Diagnostic delay at diagnosis and time-to-treatment influence overall survival of pancreatic cancer patients. Co-author DOI 10.1016/j.dld.2025.03.009↗
  5. From classical approaches to artificial intelligence, old and new tools for PDAC risk stratification and prediction. Co-author DOI 10.1016/j.semcancer.2025.03.004↗
  6. Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy. Co-author DOI 10.1002/deo2.152↗
  7. Genetic and non-genetic risk factors for early-onset pancreatic cancer. Co-author DOI 10.1016/j.dld.2023.02.023↗
  8. Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians. Co-author DOI 10.1186/s40659-023-00457-y↗
  9. Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study. Co-author DOI 10.4103/eus-d-21-00111↗
  10. [The role of endoscopic ultrasound in diagnosis and staging of pancreatic ductal adenocarcinoma.] Co-author DOI 10.1701/3525.35126↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Paolo Giorgio Arcidiacono · 6 shared papers, 2021–2026 · strength 1.37
  2. Gabriele Capurso · 5 shared papers, 2022–2026 · strength 1.09
  3. Gaetano Lauri · 3 shared papers, 2025–2026 · strength 0.80
  4. Massimo Falconi · 4 shared papers, 2022–2025 · strength 0.71
  5. Lívia Archibugi · 3 shared papers, 2023–2025 · strength 0.55
  6. Maria Chiara Petrone · 3 shared papers, 2022–2025 · strength 0.48
  7. Ruggero Ponz de Leon Pisani · 2 shared papers, 2025 · strength 0.41
  8. Antonio Facciorusso · 1 shared paper, 2026 · strength 0.39
  9. Stefano Crippa · 2 shared papers, 2023–2025 · strength 0.37
  10. Sabrina Gloria Giulia Testoni · 2 shared papers, 2023–2025 · strength 0.36
  11. Gemma Rossi · 2 shared papers, 2023–2025 · strength 0.32
  12. Giuseppe Vanella · 2 shared papers, 2023–2025 · strength 0.32
  13. Michele Reni · 2 shared papers, 2023–2025 · strength 0.32
  14. Claudio Doglioni · 2 shared papers, 2022–2023 · strength 0.30
  15. Giovanni Marchegiani · 1 shared paper, 2025 · strength 0.23
  16. Riccardo Farinella · 1 shared paper, 2025 · strength 0.22
  17. Ricardo Blázquez‐Encinas · 1 shared paper, 2025 · strength 0.22
  18. Giulia Peduzzi · 1 shared paper, 2025 · strength 0.22
  19. Daniele Campa · 1 shared paper, 2025 · strength 0.22
  20. Manuel Gentiluomo · 1 shared paper, 2025 · strength 0.22
  21. Eithne Costello · 1 shared paper, 2025 · strength 0.22
  22. Marina Macchini · 1 shared paper, 2025 · strength 0.18
  23. Giovanni Guarneri · 1 shared paper, 2025 · strength 0.18
  24. Giulia Orsi · 1 shared paper, 2025 · strength 0.18
  25. Domenico Tamburrino · 1 shared paper, 2025 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.